Basic Info.
Model NO.
Royall
Type
Pharmaceutical Intermediates
Appearance
Powder
Quality
Refined
Colour
White
Product Name
Favipiravir Intermediate
CAS
356783-28-3
Purity
99%Min
Package
Aluminum Oil Bag
Grade
Pharma Grade
Transport Package
Carton, Drum
Specification
25KG/drum
Trademark
Royall
Origin
China
Production Capacity
10000kg/Month
Product Description
Hangzhou Jinlan Pharm-Drugs Technology Co., Ltd. (JL Pharm) is established in 2012 at the beautiful West Lake - Hangzhou city, China. The company's main business includes R&D, Production and Sales of Formulation, APIs, and intermediates. The company's main products include Antiviral products, Contrast Media, related formulation, intermediates, and new product development.
We has a laboratory of 1200 square meters in Nanjing city, and has cooperative GMP production plants in Beijing, Jiangsu, Zhejiang, Jiangxi, Chengdu and Shandong. We have more than 80 technical staff, the company's management team has experience in R&D, GMP production, analysis, registration, etc. The technical management level is in a leading position in the pharmaceutical industry. We provide CDMO technology research and development services, and provides a full range of laboratory R&D and production services for raw materials and pharmaceutical intermediates to global pharmaceutical companies, including synthetic route research and development, process research and development and optimization, scale-up production, domestic and foreign drug registration, and industrial equipment selection, automatic control system and technical process packages.
Antivial products include: Redisevir, Hydroxychloroquine Sulfate, Abidol Sulfate, Oseltamivir Phosphate, Ritonavir, Lopinavir, etc. And related preparations and intermediates.
Contrast products: Iohexol, Iopamidol, Iodixanol, Iopromide, Ioversol, Iomepride, Gadopentate meglumine, Gadoterate, etc. And related preparations and intermediates.
We has a laboratory of 1200 square meters in Nanjing city, and has cooperative GMP production plants in Beijing, Jiangsu, Zhejiang, Jiangxi, Chengdu and Shandong. We have more than 80 technical staff, the company's management team has experience in R&D, GMP production, analysis, registration, etc. The technical management level is in a leading position in the pharmaceutical industry. We provide CDMO technology research and development services, and provides a full range of laboratory R&D and production services for raw materials and pharmaceutical intermediates to global pharmaceutical companies, including synthetic route research and development, process research and development and optimization, scale-up production, domestic and foreign drug registration, and industrial equipment selection, automatic control system and technical process packages.
Antivial products include: Redisevir, Hydroxychloroquine Sulfate, Abidol Sulfate, Oseltamivir Phosphate, Ritonavir, Lopinavir, etc. And related preparations and intermediates.
Contrast products: Iohexol, Iopamidol, Iodixanol, Iopromide, Ioversol, Iomepride, Gadopentate meglumine, Gadoterate, etc. And related preparations and intermediates.
Basic Info
Chemical Name | 3,6-Difluoropyrazine-2-carbonitrile |
Synonyms | QC-769;2-Pyrazinecarbonitrile,3,6-difluoro;3,6-difluoro-2-pyrazinecarbonitrile; |
CAS No. | 356783-28-3 |
Molecular Formula | C5HF2N3 |
Molecular Weight | 141.07800 |
PSA | 49.57000 |
LogP | 0.62648 |
Numbering system
| MDL number | MFCD22199270 |
Safety Info
HS Code | 2933990090 |
